E6007

DRUG3 trials

Sponsors

Eisai Inc., Eisai Co., Ltd., EA Pharma Co., Ltd.

Conditions

Healthy VolunteersInflammatory Bowel DiseaseModerate Active Ulcerative Colitis

Phase 1

A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects

CompletedNCT01221818

Eisai Inc.Inflammatory Bowel Disease

Start: 2010-09-30Updated: 2014-07-11

Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects

CompletedNCT02268838

Eisai Co., Ltd.Healthy Volunteers

Start: 2014-10-31End: 2015-11-30Updated: 2016-01-20

Phase 2

Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis

CompletedNCT03018054

EA Pharma Co., Ltd.Moderate Active Ulcerative Colitis

Start: 2016-11-28End: 2019-08-16Updated: 2019-10-04